Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125850173 | 12585017 | 3 | F | 201605 | 20160720 | 20160723 | 20160912 | EXP | US-ASTRAZENECA-2015SF23413 | ASTRAZENECA | 20668.00 | DY | M | Y | 186.00000 | KG | 20160912 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125850173 | 12585017 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG , TWO TIMES A DAY | 21929 | ||||||||||
| 125850173 | 12585017 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG , TWO TIMES A DAY | 21929 | ||||||||||
| 125850173 | 12585017 | 3 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | U | U | 0 | TABLET | ||||||||
| 125850173 | 12585017 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 125850173 | 12585017 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | 0 | 100 | MG | CAPSULE | TID | |||||||
| 125850173 | 12585017 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 125850173 | 12585017 | 7 | C | ZOCOR | SIMVASTATIN | 1 | 0 | ||||||||||||
| 125850173 | 12585017 | 8 | C | CILOSTAZOL. | CILOSTAZOL | 1 | 0 | 100 | MG | BID | |||||||||
| 125850173 | 12585017 | 9 | C | PREDNISONE. | PREDNISONE | 1 | 2.0DF UNKNOWN | 0 | 2 | DF | |||||||||
| 125850173 | 12585017 | 10 | C | PROVENTIL | ALBUTEROL | 1 | TWO PUFFS EVERY SIX HOURS AS NEEDED | 0 | |||||||||||
| 125850173 | 12585017 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | 300 | MG | QD | |||||||||
| 125850173 | 12585017 | 12 | C | TORASEMIDE | TORSEMIDE | 1 | 0 | 20 | MG | BID | |||||||||
| 125850173 | 12585017 | 13 | C | CLOBETASOL | CLOBETASOL | 1 | 0.05 %, MANUFACTURER BY TARO | 0 | OINTMENT | ||||||||||
| 125850173 | 12585017 | 14 | C | DIAZEPAM. | DIAZEPAM | 1 | 10.0MG UNKNOWN | 0 | 10 | MG | |||||||||
| 125850173 | 12585017 | 15 | C | HYDROCODONE | HYDROCODONE | 1 | 10.0MG UNKNOWN | 0 | 10 | MG | |||||||||
| 125850173 | 12585017 | 16 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 325.0MG UNKNOWN | 0 | 325 | MG | |||||||||
| 125850173 | 12585017 | 17 | C | BENAZEPRIL | BENAZEPRIL HYDROCHLORIDE | 1 | 0 | 20 | MG | QD | |||||||||
| 125850173 | 12585017 | 18 | C | BENAZEPRIL | BENAZEPRIL HYDROCHLORIDE | 1 | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125850173 | 12585017 | 1 | Chronic obstructive pulmonary disease |
| 125850173 | 12585017 | 2 | Pulmonary congestion |
| 125850173 | 12585017 | 3 | Constipation |
| 125850173 | 12585017 | 4 | Blood cholesterol abnormal |
| 125850173 | 12585017 | 5 | Neuropathy peripheral |
| 125850173 | 12585017 | 8 | Cardiovascular disorder |
| 125850173 | 12585017 | 9 | Dyspnoea |
| 125850173 | 12585017 | 10 | Dyspnoea |
| 125850173 | 12585017 | 11 | Gout |
| 125850173 | 12585017 | 12 | Fluid retention |
| 125850173 | 12585017 | 13 | Cellulitis |
| 125850173 | 12585017 | 14 | Anxiety |
| 125850173 | 12585017 | 15 | Back disorder |
| 125850173 | 12585017 | 16 | Back disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125850173 | 12585017 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125850173 | 12585017 | Bacterial infection | |
| 125850173 | 12585017 | Blood cholesterol increased | |
| 125850173 | 12585017 | Eye swelling | |
| 125850173 | 12585017 | Fatigue | |
| 125850173 | 12585017 | Headache | |
| 125850173 | 12585017 | Localised infection | |
| 125850173 | 12585017 | Muscle disorder | |
| 125850173 | 12585017 | Neuropathy peripheral | |
| 125850173 | 12585017 | Peripheral swelling | |
| 125850173 | 12585017 | Pneumonia | |
| 125850173 | 12585017 | Sleep disorder due to general medical condition, insomnia type | |
| 125850173 | 12585017 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |